YOUR SEARCH FOR Text 261 RESULTS
171 of Total
0001558370-22-011631 | 10-Q | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Aug 2, 2022 Document Date Jun 30, 2022 Form
172 of Total
0001950047-26-009470 | 144 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 144 Filing Date Sep 15, 2026 Document Date Sep 15, 2026 Form
173 of Total
0001950047-26-010228 | 144 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 144 Filing Date Oct 15, 2026 Document Date Oct 15, 2026 Form
174 of Total
0001177917-26-000014 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Oct 2, 2026 Document Date Sep 30, 2026 Form
175 of Total
0001193125-26-412653 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Oct 2, 2026 Document Date Sep 30, 2026 Form
176 of Total
0001205703-26-000030 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Sep 17, 2026 Document Date Sep 15, 2026 Form
177 of Total
0001205703-26-000032 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Oct 19, 2026 Document Date Oct 15, 2026 Form
178 of Total
0001409601-26-000015 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Oct 2, 2026 Document Date Sep 30, 2026 Form
179 of Total
0002039219-26-000010 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Oct 5, 2026 Document Date Oct 1, 2026 Form
180 of Total
0002085970-26-000007 | 4 | Incyte
Annual Reports Quarterly Reports SEC Filings SEC Filing Details Document Details Form 4 Filing Date Sep 24, 2026 Document Date Sep 22, 2026 Form
A New Frontier
in Hematology
Incyte proudly adds VGA039 and the
VIVID study to its hematology portfolio.